Find MK-3207 HCl Inhibitor, Potent CGRP Receptor Antagonist, CGRP Receptor Inhibitor on Industry Directory, Reliable Manufacturer/Supplier/Factory from China.

Inquiry Basket (0)
Home > Products > GPCR & G Protein > CGRP Receptor Inhibitor > MK-3207 HCl 957116-20-0

MK-3207 HCl 957116-20-0

Product Description

.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}


Molecular Weight:

594.05 MK-3207 is a Potent CGRP Receptor Antagonist with IC50 and Kiof 0.12 nM and 0.022 nM, highly selective versus human AM1, AM2, CTR, and AMY3. Phase 2.

Biological Activity

MK 3207 exhibits significantly higher affinity for both native and
recombinant human CGRP receptor, as well as rhesus monkey CGRP receptor
with Ki of 24 pM, ~24 pM and 22 pM, respectively, as compared to CGRP receptors from other species, including canine and rodent (Ki values of ~10 nM).


Although has affinity for AMY1 (CTR/RAMP1) receptor with a Ki value of 0.75 nM, MK 3207 displays marked selectivity for human CGRP receptor versus related human AM1 (CLR/RAMP2) receptor, AM2 (CLR/RAMP3) receptor, AMY3 (CTR/RAMP3) receptor, and CTR with Ki values of 16.5 μM, 0.156 μM, 0.128 μM and 1.9 μM, respectively.


MK 3207
potently inhibits human α-CGRP-induced cAMP production in HEK293 cells
stably expressing human CLR/RAMP1 with an IC50 of 0.12 nM, and maintains
similar potency in the presence of 50% human serum with an IC50 of 0.17
nM, indicating that the activity of MK 3207 would not be dramatically
affected by plasma protein binding in vivo. MK 3207 exhibits
approximately 65-fold more potent in the human serum-shifted in vitro
functional assay than telcagepant with an IC50 of 10.9 nM.


Administration of MK 3207 produces a concentration-dependent inhibition
of capsaicin-induced dermal vasodilation in rhesus monkeys, blocking the
blood flow increase with an EC50 of 0.8 nM and an EC90 of 7 nM,
respectively. MK 3207 displays approximately 100-fold more potent in the
rhesus monkey CIDV assay versus telcagepant with an EC90 of 994 nM.


Contact us if you need more details on 957116-20-0. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about MK-3207 HCl 957116-20-0、957116-20-0 MK-3207 HCl. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : GPCR & G Protein > CGRP Receptor Inhibitor